13 Apr 2022 07:00
The information contained within this announcement is deemed by the Company to constitute inside
information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of
the law of England and Wales. Upon the publication of this announcement via the Regulatory
Information Service, this inside information is now considered to be in the public domain.
Press release
13 April 2022
Cellular Goods PLC
('Cellular Goods' or 'the Company')
Update on ingestibles product range
Further to the announcement of 11 April 2022, the Company provides an update concerning its communications with the Food Standards Authority ("FSA") with regards to its ingestibles range.
The FSA's current position is that any new products not on sale before February 2020 are not eligible for the public list and therefore should not be available for sale. As announced previously, the Company's branded products are manufactured and supplied by Chanelle McCoy Health ("CMH"), whose products are validated and included on the FSA's permitted list published on 31 March 2022.
Cellular Goods is currently considering its position pending advice from the company's advisers and is also seeking further clarification on the FSA's stance, considering that these products are identical to the validated products from CMH. The Company's skincare range, which accounts for the bulk of its overall sales, remains unaffected.
For further information please contact:
Cellular Goods | |
Anna Chokina Chief Executive Neil Thapar Investor Relations | via Tancredi +44 207 887 7633
+44 787 645 5323 |
Tennyson Securities | |
Corporate Broker Peter Krens |
+44 207 186 9030 |
Novum Securities | |
Corporate Broker Colin Rowbury Jon Belliss |
+44 207 399 9427 |
Tancredi Intelligent Communication | |
Media Relations Helen Humphrey Gabriela Amaya Garcia Charlie Hobbs cellulargoods@tancredigroup.com |
+44 744 922 6720 +44 791 503 5294 +44 789 755 7112 |
About Cellular Goods PLC:
Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com
CBX.L (CBX)